Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and SunitinibStefania Gorini(IRCCS Ospedale San Raffaele), Elisabetta Ferraro(Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele)Oxidative Medicine and Cellular LongevityJanuary 1, 201810.1155/2018/7582730Cited by 324SaveCiteExport RISWatch citationsRelated PapersModulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumor-bearing c26 mice|Oncotarget|2017|45